Department of Pharmacy, Jashore University of Science and Technology, Jashore, 7408, Bangladesh.
Department of Genetic Engineering and Biotechnology, Jashore University of Science and Technology, Jashore, 7408, Bangladesh.
J Ethnopharmacol. 2021 Dec 5;281:114577. doi: 10.1016/j.jep.2021.114577. Epub 2021 Aug 28.
Consumable herbs play a basic part in sustenance and human health. Traditionally, Colocasia gigantea Hook (Araceae) is used to treat fever, infection, wounds healing, drowsiness, tuberculosis, stomach problems etc. AIM OF THE STUDY: The study aspired to identify bioactive compounds, to evaluate anti-inflammatory and analgesic potentials of edible herb C. gigantea, and to molecular docking study against anti-inflammatory enzyme Cyclooxygenase-2 (COX-2).
Chemical components of C. gigantea were discerned by HPLC and GCMS assays. In vitro anti-inflammatory activity was appraised by heat-induced, hypotonicity, and hydrogen peroxide-induced hemolysis assays and in vivo by formalin-induced paw edema assay. In vivo analgesic activity was evaluated by acetic acid-induced pain modulation assay. Also, molecular docking of the identified compounds was explored against the anti-inflammatory enzyme cyclooxygenase-2.
HPLC-DAD analysis divulged the presence of trans-cinnamic acid along with (-)-epicatechin as a prime component. Also, 9, 12-Octadecadienoic acid (37.86%) and n-Hexadecanoic acid (25.89%) as the major as well as 24 other compounds were confirmed through GCMS in the extract. In in vitro anti-inflammatory study, C. gigantea extract indicated prominent erythrocyte membrane stabilization activity with good percentage aegis in all experimental assays. In addition to, formalin-induced in vivo anti-inflammatory assay revealed the maximum (42.37% and 48.72%) suppression of edema at the fourth hour at 250 and 500 mg/kg body weight, respectively. Moreover, an in-vivo pain modulation assay exposed significant (p < 0.05) activity at experimental doses. Furthermore, in the docking study, (-)-epicatechin was more active rather than other identified compounds with strong binding affinity to COX-2 protein.
The extract evinced remarkable anti-inflammatory and analgesic activities. Identified bioactive components along with other components of the extract might play a pivotal role in the observed bioactivity and the results vindicate the use of edible herb C. gigantea in ancestral medicine.
可食用草药在维持人类健康方面起着基本作用。传统上,巨芋(天南星科)被用于治疗发热、感染、伤口愈合、嗜睡、肺结核、胃病等。
本研究旨在鉴定生物活性化合物,评估可食用巨芋的抗炎和镇痛潜力,并对抗炎酶环氧化酶-2(COX-2)进行分子对接研究。
通过 HPLC 和 GCMS 分析鉴定巨芋的化学成分。通过热诱导、低渗性和过氧化氢诱导的溶血试验评估体外抗炎活性,通过福尔马林诱导的爪肿胀试验评估体内抗炎活性。通过醋酸诱导的疼痛调制试验评估体内镇痛活性。此外,还探索了鉴定出的化合物与抗炎酶环氧化酶-2的分子对接。
HPLC-DAD 分析表明,反式肉桂酸和(-)-表儿茶素是主要成分。此外,GCMS 还证实提取物中含有 9,12-十八碳二烯酸(37.86%)和正十六烷酸(25.89%)等主要成分以及 24 种其他化合物。在体外抗炎研究中,巨芋提取物在所有实验中均表现出显著的红细胞膜稳定活性,并具有良好的保护百分比。此外,在体内福尔马林诱导的抗炎试验中,250 和 500mg/kg 体重时,在第四小时分别对水肿的最大抑制率为 42.37%和 48.72%。此外,体内疼痛调制试验显示在实验剂量下具有显著(p<0.05)的活性。此外,在对接研究中,(-)-表儿茶素比其他鉴定出的化合物更具活性,与 COX-2 蛋白具有较强的结合亲和力。
提取物表现出显著的抗炎和镇痛活性。鉴定出的生物活性成分以及提取物中的其他成分可能在观察到的生物活性中发挥关键作用,结果证实了可食用巨芋在传统医学中的应用。